[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Metsera, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$mtsr.png) Metsera, Inc. Common Stock (MTSR)

Pfizer acquires Metsera for $XXX billion, sending MTSR shares soaring. The deal gives Pfizer a foothold in the booming obesity treatment market.

### About Metsera, Inc. Common Stock
Metsera, Inc. Common Stock (MTSR) is a stock of a company focused on developing protein drugs for obesity treatment.  
Metsera, Inc. Common Stock uses the ticker $MTSR for trading. Listed in the [Stocks](/list/stocks) and  category.

### Insights [#](/topic/$mtsr/insights)
- Metsera, Inc. Common Stock (MTSR) social dominance is up XXX% from the previous month.
- Metsera, Inc. Common Stock (MTSR) galaxy score™ is up XXXXX% from the previous month.

### Price: $XXXXX [#](/topic/$mtsr/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/close.tsv)  
The price action is likely driven by the Pfizer acquisition news, with the stock price hitting a 52-week high. The positive sentiment from the acquisition and the potential of Metsera's pipeline are likely contributing to the price increase.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| -XXXX%  | XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2025-09-22  
**1-Year Low**: $XXXXX on 2025-04-10  
  
  
### AltRank: XXXXX [#](/topic/$mtsr/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/alt_rank.tsv)  
Metsera, Inc. Common Stock (MTSR) is currently AltRank #1,331 based on combined combined social and market metrics
**Daily Average**: XXXXX  
**1 Week**: XXX +287  
**1 Month**: XXXXX -XXX  
**6 Months**: XXXXX +1,115  
**1 Year**: XXXXX -XXX  
**1-Year High**: XXXXX on 2025-07-28  
**1-Year Low**: XX on 2025-09-22  
  
  
### Galaxy Score: XXXXX [#](/topic/$mtsr/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +21  
**1 Month**: XX +35  
**6 Months**: XX +3  
**1 Year**: XX +34  
**1-Year High**: XX on 2025-09-22  
**1-Year Low**: XX on 2025-05-09  
  
  
### Engagements: XXXXX [#](/topic/$mtsr/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXXXX +393%  
**6 Months**: XXXXXXXXX +371%  
**1 Year**: XXXXXXXXX +307%  
**1-Year High**: XXXXXXX on 2025-09-22  
**1-Year Low**: X on 2024-10-26  

| Social Network | X     | Reddit |
| -------------- | -     | ------ |
| Engagements    | XXXXX | XX     |
  

  
  
### Mentions: XX [#](/topic/$mtsr/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XXXXX +343%  
**6 Months**: XXXXX +823%  
**1 Year**: XXXXX +13,474%  
**1-Year High**: XXXXX on 2025-09-23  
**1-Year Low**: X on 2024-10-26  

| Social Network | X   | Reddit |
| -------------- | -   | ------ |
| Mentions       | XXX | X      |
  

  
  
### Creators: XX [#](/topic/$mtsr/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Metsera, Inc. Common Stock (MTSR) in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +419%  
**6 Months**: XXXXX +1,163%  
**1 Year**: XXXXX +9,322%  
**1-Year High**: XXXXX on 2025-09-23  
**1-Year Low**: X on 2024-10-22  

The most influential creators that mention Metsera, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | X    | XXXXXX    | X     | XXXXX       |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA)       | X    | XXXXX     | X     | XXX         |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | X    | XXXXXX    | X     | XXX         |
| [@GilaMonstrum](/creator/twitter/GilaMonstrum)       | X    | XXXXX     | X     | XXX         |
| [@MeadowCapital](/creator/twitter/MeadowCapital)     | X    | XXXXX     | X     | XXX         |
| [@SamFazeli8](/creator/twitter/SamFazeli8)           | X    | XXXXX     | X     | XXX         |
| [@Optimistic24228](/creator/twitter/Optimistic24228) | X    | XXX       | X     | XXX         |
| [@prasadchoragud1](/creator/twitter/prasadchoragud1) | X    |           | X     | XX          |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XX          |
| [@jfais20](/creator/twitter/jfais20)                 | XX   | XXXXXX    | X     | XX          |

[View More](/list/creators/$mtsr/100)
  
  
### Sentiment: XX% [#](/topic/$mtsr/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-11-20  
**1-Year Low**: XX% on 2025-01-13  

**Most Supportive Themes**
- **Pfizer Acquisition:** (55%) Pfizer's acquisition of Metsera is viewed as a major positive, injecting capital and resources into the company's obesity drug pipeline.
- **Positive Data and Pipeline:** (25%) The potential of Metsera's lead drug and other molecules in the clinic, along with the company's innovative technology, are highlighted as key strengths.
- **Market Opportunity:** (10%) The booming obesity treatment market and the potential for Metsera to capture a significant share are driving positive sentiment.
  
**Most Critical Themes**
- **Valuation Concerns:** (5%)  Some investors question whether the acquisition price is justified, especially compared to the valuations of other companies in the space.
- **Competition:** (5%)  The competitive landscape in the obesity drug market, with established players like Eli Lilly and Novo Nordisk, poses a challenge.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
| Reddit  | X        | X%  | XX      | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$mtsr/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.003%  
**1 Month**: XXXXX% +0.014%  
**6 Months**: XXXXX% +0.0075%  
**1 Year**: XXXXX% +0.016%  
**1-Year High**: XXXXX% on 2025-09-23  
**1-Year Low**: XXXXXX% on 2024-12-07  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$mtsr/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2025-04-10  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mtsr/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$1.30%  
**1 Month**: $XXXXXXXXXXXXX +$59%  
**6 Months**: $XXXXXXXXXXXXX +$145%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-09-22  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-10  

**Top assets mentioned**
In the posts about Metsera, Inc. Common Stock in the last XX hours

[Viking Therapeutics, Inc (VKTX)](/topic/$vktx)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Novo-Nordisk (NVO)](/topic/$nvo)
[Akropolis (AKRO)](/topic/$akro)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Merus N.V. Common Shares (MRUS)](/topic/$mrus)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[AbbVie Inc (ABBV)](/topic/$abbv)

**Top topics mentioned**
In the posts about Metsera, Inc. Common Stock in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$vktx](/topic/$vktx), [$pfe](/topic/$pfe), [$nvo](/topic/$nvo), [acquisition](/topic/acquisition), [$gpcr](/topic/$gpcr), [$akro](/topic/$akro), [$xbi](/topic/$xbi), [eli lilly](/topic/eli-lilly), [$psnl](/topic/$psnl), [stocks technology](/topic/stocks-technology), [$mrus](/topic/$mrus), [$etnb](/topic/$etnb), [$mrk](/topic/$mrk), [stocks](/topic/stocks), [$abbv](/topic/$abbv), [investment](/topic/investment), [$cytk](/topic/$cytk), [$oklo](/topic/$oklo), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [weight loss](/topic/weight-loss), [$amgn](/topic/$amgn), [has been](/topic/has-been), [$bbio](/topic/$bbio), [chopped](/topic/chopped), [$abvx](/topic/$abvx), [$mens](/topic/$mens), [$10b](/topic/$10b), [$375b](/topic/$375b), [$808m](/topic/$808m), [$trml](/topic/$trml), [$mdgl](/topic/$mdgl), [$rna](/topic/$rna), [$apge](/topic/$apge), [behind the](/topic/behind-the), [market cap](/topic/market-cap), [$geos](/topic/$geos), [$indi](/topic/$indi), [coins made in usa](/topic/coins-made-in-usa), [coins base ecosystem](/topic/coins-base-ecosystem), [coins arbitrum](/topic/coins-arbitrum), [money](/topic/money), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [$mngl](/topic/$mngl), [$insm](/topic/$insm), [$axm](/topic/$axm), [$crnx](/topic/$crnx), [$celh](/topic/$celh), [$fcx](/topic/$fcx), [$smtc](/topic/$smtc), [$bmy](/topic/$bmy), [$csan](/topic/$csan), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$qubt](/topic/$qubt), [bitmine](/topic/bitmine), [$nbi](/topic/$nbi), [$lly](/topic/$lly), [$agio](/topic/$agio), [$btsg](/topic/$btsg), [$crsp](/topic/$crsp), [$ehc](/topic/$ehc), [$gh](/topic/$gh), [$ptgx](/topic/$ptgx), [johnson johnson](/topic/johnson-johnson), [$jnj](/topic/$jnj), [$prax](/topic/$prax), [$nvts](/topic/$nvts), [$actu](/topic/$actu), [$alms](/topic/$alms), [$bhc](/topic/$bhc), [bolt token](/topic/bolt-token), [coins](/topic/coins), [$orcl](/topic/$orcl), [$gpc](/topic/$gpc), [$coop](/topic/$coop), [novartis](/topic/novartis), [$ssrm](/topic/$ssrm), [autocrypto](/topic/autocrypto), [coins bsc](/topic/coins-bsc), [coins ai](/topic/coins-ai), [$au](/topic/$au), [$gubra](/topic/$gubra), [china](/topic/china), [$bntx](/topic/$bntx), [$bny](/topic/$bny), [$smmt](/topic/$smmt), [$idya](/topic/$idya), [doc](/topic/doc), [patience](/topic/patience), [$amg](/topic/$amg), [$sony](/topic/$sony), [$mo](/topic/$mo), [$rprx](/topic/$rprx), [$puk](/topic/$puk), [$azn](/topic/$azn), [$joby](/topic/$joby), [$16b](/topic/$16b), [$frsh](/topic/$frsh), [$asts](/topic/$asts)

### Top Social Posts [#](/topic/$mtsr/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$XBI Selected Therapies in Development for Obesity Courtesy the incomparable @NatRevDrugDisc (Editor: and pre $MTSR buyout by $PFE) "  
[X Link](https://x.com/PersimmonTI/status/1979900758955868313) [@PersimmonTI](/creator/x/PersimmonTI) 2025-10-19T13:21Z 10.3K followers, 1859 engagements


"@PGainz96934 You already lost. I am trying to tell you why. Good luck though. I was in $MTSR because they are a really good obesity company. Now I am out with XXX% gain. I don't mind the worse investor if I am making XXX% gains"  
[X Link](https://x.com/Biotech2k1/status/1979882333827461440) [@Biotech2k1](/creator/x/Biotech2k1) 2025-10-19T12:08Z 32.4K followers, XX engagements


"Air Taxi $BETA IPO Eyes XXXX Billion Valuation **Other Leading New Issues This Year $MENS $CRCL $CRWV $KRMN $MTSR $AAPG $MIAX $WYFI"  
[X Link](https://x.com/STaylor76084368/status/1979643980859248715) [@STaylor76084368](/creator/x/STaylor76084368) 2025-10-18T20:21Z XXX followers, XXX engagements


"Best stock advice right now Investing in zero revenues unicorns. YEAR-TO-DATE HEAT MAP OF STOCKS WITH $1B+ MARKET CAP & $1M REVENUES $OKLO +642% $JOBY +98% $CALC -X% $NEUP +417% $SNSE +3313% $MTSR +99% $QUBT 0%"  
[X Link](https://x.com/ValueSense_io/status/1979366868885328152) [@ValueSense_io](/creator/x/ValueSense_io) 2025-10-18T02:00Z 42.5K followers, 3463 engagements